Cargando…
Serum glial fibrillary acidic protein as a biomarker of brain injury in premature neonates
Neonatal brain injury (NBI) is a serious adverse outcome of prematurity. Early detection of high risk premature neonates to develop NBI is not currently feasible. The predictive value of many biomarkers has been tested, but none is used in clinical practice. The purpose of this study was to determin...
Autores principales: | Metallinou, Dimitra, Karampas, Grigorios, Nyktari, Georgia, Iacovidou, Nicoletta, Lykeridou, Katerina, Rizos, Demetrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860316/ https://www.ncbi.nlm.nih.gov/pubmed/34278985 http://dx.doi.org/10.17305/bjbms.2021.6205 |
Ejemplares similares
-
Serum Activin A as Brain Injury Biomarker in the First Three Days of Life. A Prospective Case—Control Longitudinal Study in Human Premature Neonates
por: Metallinou, Dimitra, et al.
Publicado: (2021) -
Investigation of Healthcare Professionals’ Knowledge of Evidence-Based Clinical Practices for Preterm Neonatal Skin Care—A Pilot Study
por: Metallinou, Dimitra, et al.
Publicado: (2022) -
Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022) -
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
por: Aktas, Orhan, et al.
Publicado: (2021) -
Knowledge of Critical Issues in the Intrapartum Period: a Cross-sectional Study Among Undergraduate Final Year Midwifery Students
por: Liagkou, Anastasia, et al.
Publicado: (2022)